The natural history of thyroid function abnormalities after treatment for childhood cancer

European Journal of Cancer

Volumn 43, Issue 7, 2007, Pages 1161-1170

  Madanat, Laura Maria S ^a   Lähteenmäki, Päivi M ^a   Alin, Jouni ^b   Salmi, Toivo T ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Cancer; Child; Late effect; Survivor; Thyroid

Indexed keywords

ALKYLATING AGENT;

ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILDHOOD CANCER; FEMALE; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; THYROID DISEASE; THYROID FUNCTION; WHOLE BODY RADIATION;

ADOLESCENT; AGE OF ONSET; ANTINEOPLASTIC AGENTS; CHILD; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; RADIOTHERAPY; SURVIVORS; THYROID DISEASES; THYROID FUNCTION TESTS;

EID: 34247157199     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.01.036     Document Type: Article

References (36)

1. Möller T.R., Garwicz S., Barlow L., et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 19 (2001) 3173-3181
2. Anderson D., Rennie K., Ziegler R., Neglia J.P., Robison L.R., and Gurney J.G. Medical and neurocognitive late effects among survivors of childhood central nervous system tumors. Cancer 92 (2001) 2709-2719
3. Oeffinger K.C., Eshelman D.A., Tomlinson G.E., Buchanan G.R., and Foster B.M. Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer 88 (2000) 1687-1695
4. Van den Bos C., Heinen R.C., Sukel M., van der Pal H.J.H., and Geenen M.M. Screening for late effects in survivors of childhood cancer: growth hormone deficiency from a pediatric oncologist's point of view. Growth Horm IGF Res 14 (2004) 125-128
5. Darzy K.H., and Shalet S.M. Radiation induced growth hormone deficiency. Horm Res 59 (2003) 1-11
6. Shalet S.M. Radiation and pituitary dysfunction. N Engl J Med 14 (1993) 87-94
7. Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 33 (1999) 2-8
8. Kremer L.C., van Dalen E.C., Offringa M., Ottenkamp J., and Voute P.A. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 19 (2001) 191-196
9. Lipshultz S.E., Rifai N., Dalton V.M., et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 351 (2004) 145-153
10. Mulhern R.K., Merchant T.E., Gajjar A., Reddick W.E., and Kun L.E. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5 (2004) 399-408
11. Eiser C. Cognitive deficits in children treated for leukemia. Arch Dis Child 66 (1991) 164-168
12. Heikens J., Michiels E.M., Behrendt H., Endert E., Bakker P.J., and Fliers E. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. Eur J Cancer 34 (1998) 1592-1597
13. Oberfield S.E., and Sklar C.A. Endocrine sequelae in survivors of childhood cancer. Adolesc Med 13 (2002) 161-169
14. Schmiegelow M., Feldt-Rasmussen U., Rasmussen A.K., Lange M., Poulsen H.S., and Muller J. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab 88 (2003) 3149-3154
15. Oberfield S.E., Allen J.C., Pollack J., New M.I., and Levine L.S. Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function. J Pediatr 108 (1986) 219-223
16. Tell R., Lundell G., Nilsson B., Sjodin H., Lewin F., and Lewensohn R. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. it Int J Radiat Oncol Biol Phys 60 (2004) 395-400
17. Hancock S.L., Cox R.S., and McDougall I.R. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325 (1991) 599-605
18. Sklar C., Whitton J., Mertens A., et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the childhood cancer survivor study. J Clin Endocrinol Metab 85 (2000) 3227-3232
19. Spoudeas H.A. Growth and endocrine function after chemotherapy and radiotherapy in childhood. Eur J Cancer 38 (2002) 1748-1759
20. Van Santen H.M., Vulsma T., Dijkgraaf M.G., et al. No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer. J Clin Endocrinol Metab 88 (2003) 3657-3663
21. Schmiegelow M., Feldt-Rasmussen U., Rasmussen A.K., Poulsen H.S., and Muller J. A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. J Clin Endocrinol Metab 88 (2003) 136-140
22. Subcliffe S.B., Chapman R., and Wrigley P.F.M. Cyclical combination chemotherapy and thyroid function in patients with advanced Hodgkin's disease. Med Pediatr Oncol 9 (1981) 439-448
23. Stuart N.S.A., Woodroffe C.M., Grundy R., and Cullen M.H. Long-term toxicity of chemotherapy for testicular cancer- the cost of cure. Br J Cancer 61 (1990) 479-484
24. Rose S.R., Lustig R.H., Pitukcheewanont P., et al. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 84 (1999) 4472-4479
25. Metzger M.L., Hudson M.M., Somes G.W., et al. White Race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's Lymphoma. J Clin Oncol 24 (2006) 1516-1521
26. Livesey E.A., and Brook C.G. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 64 (1989) 593-595
27. Ogilvy-Stuart A.L., Shalet S.M., and Gattamaneni H.R. Thyroid function after treatment of brain tumors in children. J Pediatr 119 (1991) 733-737
28. Rose S.R., Schreiber R.E., Kearney N.S., et al. Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 17 (2004) 55-66
29. Nygaard R., Bjerve K.S., Kolmannskog S., Moe P.J., and Wesenberg F. Thyroid function in children after cytostatic treatment for acute leukemia. Pediatr Hematol Oncol 5 (1988) 35-38
30. Ineck B.A. Effects of subclinical hypothyroidism and its treatment on serum lipids. Ann Pharmacother 37 (2003) 725-730
31. Biondi B., Palmieri E.A., Lombardi G., and Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137 (2002) 904-914
32. Lustig R.H., Post S.R., Srivannaboon K., et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88 (2003) 611-616
33. Acharya S., Sarafoglou K., LaQuaglia M., et al. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 97 (2003) 2397-2403
34. Rivas M., and Santisteban P. TSH-activated signaling pathways in thyroid tumorigenesis. Mol Cell Endocrinol 213 (2003) 31-45
35. Mehta A., Hindmarsh P.C., Stanhope R.G., Brain C.E., Preece M.A., and Dattani M.T. Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab 88 (2003) 5696-5703
36. Collet D. Modelling survival data in medical research. 2nd ed. (2003), Chapman & Hall, London